Treatment Guidelines in Rheumatoid Arthritis-Optimizing the Best of Both Worlds

被引:2
|
作者
Jagpal, Aprajita [1 ]
Singh, Jasvinder A. [1 ,2 ,3 ]
机构
[1] Univ Alabama Birmingham, Div Rheumatol, 510 20th St S Off 836, Birmingham, AL 35233 USA
[2] Birmingham VA Med Ctr, Birmingham, AL USA
[3] UAB Sch Publ Hlth, Dept Epidemiol, 1665 Univ Blvd,Ryals Publ Hlth Bldg,Room 220, Birmingham, AL 35294 USA
关键词
Rheumatoid arthritis; Treatment guidelines; DOUBLE-BLIND; DISEASE-ACTIVITY; CERTOLIZUMAB PEGOL; TRIPLE THERAPY; COMBINATION THERAPY; PLUS METHOTREXATE; ETANERCEPT; REMISSION; DRUG; RISK;
D O I
10.1007/s40674-020-00163-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewRheumatoid arthritis (RA) leads to significant joint damage and systemic complications. Available treatment options for RA has made it possible to achieve a good control over disease activity and improve patient outcomes. In this review, we discuss management guidelines for RA and their practical application by discussing clinical scenarios commonly encountered in rheumatology practice.Recent findingsEuropean League Against Rheumatism recently updated treatment recommendations for management of RA. The general fundamentals of these recommendations are similar to those of the 2015 American College of Rheumatology guidelines for the treatment of RA but with some key distinctions. We discuss three RA cases to illustrate key aspects of treatment guidelines. New data show increased cardiovascular risk in patients with RA that is possibly related to associated systemic inflammation.SummaryWhile several questions about RA remain unanswered, the clinical outcomes have improved in recent years. A strategic approach to manage RA is recommended which involves early diagnosis and treatment and escalating treatments to achieve a therapeutic target. In addition to treating RA disease activity, management of comorbid conditions is imperative to prevent long-term systemic damage.
引用
收藏
页码:354 / 369
页数:16
相关论文
共 50 条
  • [21] Treatment Strategies in Early Rheumatoid Arthritis and Prevention of Rheumatoid Arthritis
    Demoruelle, M. Kristen
    Deane, Kevin D.
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (05) : 472 - 480
  • [22] What is the best treatment for early rheumatoid arthritis?
    Pope, Janet E.
    RHEUMATOLOGY, 2019, 58 (12) : 2086 - 2088
  • [23] Optimizing biological treatment in rheumatoid arthritis with the aid of therapeutic drug monitoring
    Eng, Grith Petersen
    DANISH MEDICAL JOURNAL, 2016, 63 (11):
  • [24] Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
    Patel, Aarat M.
    Moreland, Larry W.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 263 - 278
  • [25] Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies
    Heckert, Sascha Louise
    Maassen, Johanna M.
    Nevins, Isabell
    Baudoin, Paul
    Steup-Beekman, Gerda M.
    Huizinga, Tom W. J.
    Bergstra, Sytske Anne
    Allaart, Cornelia F.
    RHEUMATOLOGY, 2024, : 1052 - 1059
  • [26] Glucocorticold treatment in rheumatoid arthritis
    Rau, Rolf
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1575 - 1583
  • [27] Rheumatoid Arthritis Activity and Treatment
    Urbina Aucancela, Cynthia Yesenia
    Carrera Montero, Geyla Yomar
    Quintana Dominguez, Omar Santiago
    Guama Bonilla, Lucia Nataly
    REVISTA CUBANA DE REUMATOLOGIA, 2020, 22 (03):
  • [28] Adalimumab for the treatment of rheumatoid arthritis
    Miyasaka, Nobuyuki
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (01) : 19 - 26
  • [29] Etanercept in the treatment of rheumatoid arthritis
    Hunt, Laura
    Emery, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1441 - 1450
  • [30] Evolution of treatment for rheumatoid arthritis
    Upchurch, Katherine S.
    Kay, Jonathan
    RHEUMATOLOGY, 2012, 51 : 28 - 36